4D Molecular Therapeutics... (FDMT)
4.67
-0.05 (-1.06%)
At close: Jan 28, 2025, 3:02 PM
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Cash & Equivalents | 249.11M | 218.64M | 315.43M | 276.73M | 49.65M | 91.76M | 23.85M |
| Short-Term Investments | 39.12M | 161.20M | 94.78M | n/a | n/a | n/a | n/a |
| Long-Term Investments | 10.95M | 4.91M | 67.65M | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 684.00K | 1.08M | -58.55M | 602.00K | 677.00K | 429.00K | 105.00K |
| Receivables | n/a | n/a | 47.00K | 1.49M | 978.00K | 1.12M | 321.00K |
| Inventory | n/a | -5.79M | -8.50M | n/a | n/a | n/a | 1.00 |
| Other Current Assets | 8.36M | 6.96M | 8.46M | 8.89M | 1.88M | 783.00K | 328.00K |
| Total Current Assets | 296.59M | 220.51M | 315.43M | 282.66M | 52.51M | 94.07M | 24.50M |
| Property-Plant & Equipment | 31.66M | 35.35M | 28.95M | 5.07M | 5.05M | 2.47M | 2.72M |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 43.30M | 41.34M | 38.06M | 5.67M | 5.73M | 2.90M | 2.82M |
| Total Assets | 339.89M | 261.85M | 353.49M | 288.33M | 58.23M | 96.97M | 27.32M |
| Account Payables | 3.52M | 3.32M | 4.76M | 1.79M | 1.74M | 954.00K | 460.00K |
| Deferred Revenue | 273.00K | 884.00K | 2.60M | 6.59M | 5.86M | 4.91M | 4.38M |
| Short-Term Debt | 3.15M | 5.31M | 2.46M | n/a | n/a | n/a | n/a |
| Other Current Liabilities | 12.01M | 6.74M | 9.03M | 8.37M | 5.35M | 2.10M | 1.01M |
| Total Current Liabilities | 18.95M | 15.73M | 16.34M | 16.74M | 12.96M | 8.05M | 5.91M |
| Long-Term Debt | 11.52M | 13.47M | 15.22M | n/a | n/a | n/a | n/a |
| Other Long-Term Liabilities | 617.00K | 233.00K | 334.00K | 1.97M | 104.65M | 103.43M | 18.81M |
| Total Long-Term Liabilities | 13.11M | 14.78M | 18.04M | 15.20M | 118.25M | 116.50M | 41.00M |
| Total Liabilities | 32.06M | 30.51M | 560.48M | 31.94M | 131.20M | 124.56M | 46.91M |
| Total Debt | 14.67M | 16.12M | 16.45M | n/a | n/a | n/a | n/a |
| Common Stock | 4.00K | 3.00K | 3.00K | 3.00K | 1K | 1K | 1K |
| Retained Earnings | -415.33M | -314.49M | -207.00M | -135.68M | -79.03M | -30.03M | -20.48M |
| Comprehensive Income | 16.00K | -1.20M | -423.00K | -288.33M | -102.98M | -102.98M | -18.51M |
| Shareholders Equity | 307.83M | -314.49M | -207.00M | 256.39M | -72.97M | -27.59M | -19.59M |
| Total Investments | 50.08M | 166.11M | 162.43M | n/a | n/a | n/a | n/a |